Market revenue in 2023 | USD 142.6 million |
Market revenue in 2030 | USD 207.3 million |
Growth rate | 5.5% (CAGR from 2023 to 2030) |
Largest segment | Soil-transmitted helminthiases |
Fastest growing segment | Chagas disease |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne Trematode Infections, Echinococcosis, Chagas disease, Dracunculiasis, Human African Trypanosomiasis (sleeping sickness), Soil-transmitted Helminthiases, Onchocerciasis, Schistosomiasis, Scabies and Other Ecoparasites, Snakebite Envenoming, Leishmaniases |
Key market players worldwide | Roche, Abbott Laboratories, Thermo Fisher Scientific Inc, Eurobio-Scientific, Omega Laboratories, Avacta Group PLC, Oscar Health Inc Class A, ZeptoMetrix, InBios, DiaSys Diagnostic Systems |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neglected tropical diseases diagnosis market will help companies and investors design strategic landscapes.
Soil-transmitted helminthiases was the largest segment with a revenue share of 10.17% in 2023. Horizon Databook has segmented the Venezuela neglected tropical diseases diagnosis market based on dengue, chikungunya, rabies, leprosy, buruli ulcer, yaws, lymphatic filariasis, taeniasis/cysticercosis, foodborne trematode infections, echinococcosis, chagas disease, dracunculiasis, human african trypanosomiasis (sleeping sickness), soil-transmitted helminthiases, onchocerciasis, schistosomiasis, scabies and other ecoparasites, snakebite envenoming, leishmaniases covering the revenue growth of each sub-segment from 2018 to 2030.
Poverty and political instability are some of the key factors that lead to increase in the incidence of NTDs in Venezuela. According to PLOS Neglected Tropical Diseases, in the last decade, NTDs, such as malaria, have increased almost threefold in the country.
This can be attributed to illegal mining operations, with influx of migrant workers living in overcrowded and unhealthy conditions. In addition, there are severe shortages of essential antimalarial drugs and preventive insecticides, which further leads to increase in disease incidence.
Similar to malaria, the prevalence of other vector-borne diseases, such as chikungunya, dengue, and Zika virus infections, is significantly increasing. Among children, dengue remains a significant cause of illness and death. Thus, rising number of NTD cases is expected to fuel market growth in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Venezuela neglected tropical diseases diagnosis market , including forecasts for subscribers. This country databook contains high-level insights into Venezuela neglected tropical diseases diagnosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account